MINOLI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 3.158
AS - Asia 2.255
EU - Europa 1.818
SA - Sud America 258
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 45
OC - Oceania 2
AN - Antartide 1
Totale 7.582
Nazione #
US - Stati Uniti d'America 3.088
CN - Cina 1.171
SG - Singapore 508
IE - Irlanda 375
UA - Ucraina 304
DE - Germania 227
HK - Hong Kong 208
FI - Finlandia 202
BR - Brasile 183
RU - Federazione Russa 179
VN - Vietnam 173
IT - Italia 146
FR - Francia 117
GB - Regno Unito 109
SE - Svezia 86
IN - India 37
CA - Canada 33
BD - Bangladesh 30
CO - Colombia 23
AR - Argentina 22
ZA - Sudafrica 20
IQ - Iraq 19
MX - Messico 14
NL - Olanda 13
ID - Indonesia 12
JP - Giappone 12
PK - Pakistan 12
TR - Turchia 12
BE - Belgio 11
PL - Polonia 11
EC - Ecuador 10
AT - Austria 9
UZ - Uzbekistan 9
ES - Italia 8
SA - Arabia Saudita 8
JO - Giordania 7
PH - Filippine 7
CL - Cile 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
MA - Marocco 5
MY - Malesia 5
DO - Repubblica Dominicana 4
JM - Giamaica 4
KE - Kenya 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
BO - Bolivia 3
DZ - Algeria 3
EG - Egitto 3
LB - Libano 3
PA - Panama 3
TN - Tunisia 3
AZ - Azerbaigian 2
BY - Bielorussia 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
KR - Corea 2
LU - Lussemburgo 2
MU - Mauritius 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
UY - Uruguay 2
AL - Albania 1
AQ - Antartide 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
CU - Cuba 1
EU - Europa 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
NG - Nigeria 1
OM - Oman 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 7.538
Città #
Chandler 464
Dublin 375
Jacksonville 371
San Jose 276
Singapore 272
Nanjing 258
Ashburn 219
Hong Kong 208
Beijing 160
Boardman 148
Dallas 136
Nanchang 120
Council Bluffs 114
Princeton 85
Hebei 82
Shenyang 82
Wilmington 82
Lawrence 81
Changsha 79
Los Angeles 72
Lauterbourg 69
Ann Arbor 67
Ho Chi Minh City 63
Jiaxing 59
Tianjin 56
Medford 54
Hanoi 52
Hangzhou 41
Moscow 38
Buffalo 34
Munich 33
Milan 32
Helsinki 31
Santa Clara 28
Shanghai 26
São Paulo 26
Verona 25
New York 22
Woodbridge 22
Turku 20
Redondo Beach 19
Johannesburg 17
Toronto 13
Brooklyn 12
Da Nang 12
Frankfurt am Main 12
Houston 12
Orem 12
Columbus 11
Des Moines 11
Tokyo 11
Atlanta 10
Brussels 10
Guangzhou 10
Pavia 10
Stockholm 10
Kunming 9
San Francisco 9
Seattle 9
Tashkent 9
Auburn Hills 8
Baghdad 8
Norwalk 8
Phoenix 8
Pune 8
Warsaw 8
Amman 7
Fairfield 7
Las Vegas 7
Montreal 7
Amsterdam 6
Boston 6
Chicago 6
Falkenstein 6
Guayaquil 6
Medellín 6
Mexico City 6
Poplar 6
Rome 6
Chennai 5
Curitiba 5
Florence 5
Jinan 5
London 5
The Dalles 5
Ankara 4
Bogotá 4
City of London 4
Denver 4
Dhaka 4
Haiphong 4
Manchester 4
Mosul 4
Naples 4
Ningbo 4
Nuremberg 4
Rio de Janeiro 4
Taizhou 4
Zhengzhou 4
Bergamo 3
Totale 4.929
Nome #
A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports 182
A new chromosome instability disorder 156
Acute transient inflammatory leukoencephalopathy in HIV. 147
Candida infective endocarditis: report of 15 cases from a prospective multicenter study 133
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 131
Acute disseminated encephalomyelitis 129
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 127
Carbonchio 123
Postinfectious neurologic syndromes: A prospective cohort study 122
Severe recurrent myelitis in patients with hepatitis C virus infection 121
A 10-years survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian report 119
Detection of HTLV-III specific IgG in the CSF from patient with AIDS and encephalitis. 116
HIV-RELATED ACUTE INFLAMMATORY LEUKOENCEPHALOPATHY OF UNDETERMINED ORIGIN: SYSTEMATIC REVIEW OF THE LITERATURE 116
Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linted immunospot assay. 114
Low prevalence of antibodies to the HCV envelope region in anti-HCV seronegative, HCV RNA positive patients 112
Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease 110
Listeriosi 107
Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: Case report and review of the literature 107
Severe recurrent myelitis in patients with hepatitis C virus infection patients 106
Early and late effects of highly active antiretroviral therapy: a 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients 104
Long-term CD4+ T- cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 103
Sepsi e shock settico 101
Morphological, cytochemical and ultrastructural studies of a case of systemic mastocytosis. 101
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection 101
Comparison of four-drug regimens and pairs of sequential three drug regimens as initial therapy for HIV-1 infection 101
Headache attributed to infection: observations on the IHS classification (ICHD-II) 97
Severe outcome of influenza A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin: a multicenter study. 97
Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors 97
Prevalence and outcome of hepatitis B virus (HBV) infection following thoracic organ transplantation 96
Xenotropic and polytropic murine leukemia virus-related sequences are not detected in the majority of patients with chronic fatigue syndrome. 96
Evaluation of the risk factors associated with lipodystrophy development in a cohort of HIV-positive patients. 96
Post-exposure rate of tuberculosis infection among health care workers measured with tuberculin skin test convension after unprotected exposure to patients with pulmonary tuberculosis: 6 -years experience in an Italian teaching hospital 96
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1 positive patients after commencement of a new highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER COHORT 95
Hepatitis C virus (HCV) core serotypes in chronic HCV infection 94
Circadian secretory pattern of growth hormone, insulin-like growth type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone, and prolactin during HIV infection 92
Severe steroid-resistant post-infectious encephalomyelitis: general features and effects ofIVIg. 90
First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection 90
Infezioni da Brucella 90
Recruitment criteria for acute disseminated encephalomyelitis studies: the need for consensus 89
Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3 89
In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis; high in vitro synergistic effect of the association ceftriaxone-fosfomycin. 89
Osteomieliti e artriti infettive 89
Epidemiology of Mycobacterium tuberculosis infecion in Pavia province, Lombarady, Northern Italy, 1998-2013 89
Aetiology and outcome of penumoniae in HIV-positive patients in the antiretroviral era 88
Varicella zoster virus meningo-encephalo-myelitis in an immunocompetent patient 87
Visceral leishmaniasis, systemic lupus erythematosus and acute hepatitis 85
Predictors of AIDS-defining events among advanced naive patients after HAART 85
Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study 83
Infezioni da Legionella 83
Replication capacity in relation to immunological and virological outcomes in HIV-1 infected treatment-naive subjects 83
Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study 82
Malatttie da Rickettsie 81
Immune reconstitution and control of HIV 81
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal 81
Febbri ricorrenti 80
Infectious complications in patients with the novacor left ventricular assist system 80
The effect of HIV-1 resistance mutatioins after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens 80
Evaluation of cytomegalovirus DNAemia versus pp65-antigenemia cut off for guiding preemptive therapy in transplant recipients: a randomized study 79
Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz 79
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease 79
Staphylococcus aureus toxic shock syndrome toxin-1 endocarditis with muscular metastatic abscesses 78
Recruitment criteria for acute disseminated encephalomyelitis studies: the need for consensus. 77
Performance of liver stiffness measurements by transient elastography in chronic hepatitis. 76
The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens 76
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort 75
Post infectious inflammatory disorders: subgroup based on prospective follow-up 75
Performance of liver stiffness measurements by transient elastography in chronic hepatitis. 75
Exploratory analysis for the evaluation of lopinavir/ritonavir versus efavirenz- based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER COHORT 74
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 74
Infective endocarditis in patients with hepatic diseases 74
Riverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART study 70
Leptospirosi 69
Surveillance of Toxoplasma gondii infection in recipients of thoracic solid organ transplants 69
Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized-double-blind SENSE trial 69
Neuropsychological evaluation and follow up in jcv- and non-jcv-related leukoencephalopathies in HIVinfection 68
Predictors of clinical progression among HIV-1 positive patients starting HAART with CD4+ T-cell counts > or= 200 cells/mm3 67
ItalianPostinfectious Demyelinating Diseases (IPoDD) Study Group; Italian Study Group ofNeuroinfectious Diseases. Recruitment criteria for acute disseminatedencephalomyelitis studies: the need for consensus 64
Tuberculosis-induced haemophagocytic syndrome in a patient on haemodialysis treated with anti-thymocyte globulin. 61
Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients. 60
Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients. 60
Vademecum di Malattie Infettive 58
Profilassi e terapia delle infezioni micotiche nel trapianto d'organo solido. 57
Totale 7.582
Categoria #
all - tutte 32.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022299 0 0 10 7 3 6 4 20 19 2 54 174
2022/20231.237 143 86 17 126 120 144 0 69 487 0 28 17
2023/2024322 39 62 9 24 19 87 1 29 6 4 15 27
2024/2025936 17 89 24 33 21 28 88 31 221 30 97 257
2025/20262.208 171 160 241 238 271 125 423 85 185 164 92 53
2026/2027310 51 134 125 0 0 0 0 0 0 0 0 0
Totale 7.582